A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials
Fuente:
arXiv
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Preprint |
| Veröffentlicht: |
2026
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866916018387943424 |
|---|---|
| author | Zhang, Cong Long, Meihua Zheng, Tianyu Sechidis, Konstantinos Liu, Xiaoni Sun, Sophie Chen, Yao Zhang, Xinyi Kaneko, Shuhei Bornkamp, Björn Hou, Yan |
| author_facet | Zhang, Cong Long, Meihua Zheng, Tianyu Sechidis, Konstantinos Liu, Xiaoni Sun, Sophie Chen, Yao Zhang, Xinyi Kaneko, Shuhei Bornkamp, Björn Hou, Yan |
| contents | Multi-regional clinical trials (MRCTs) enable efficient global drug development by assessing treatment effects across regions within a single protocol. While powered for overall efficacy, MRCTs are typically not designed to provide confirmatory evidence on regional differences, making an assessment of observed regional heterogeneity largely exploratory and susceptible to sampling variability. Despite this challenge, understanding regional heterogeneity remains important for interpretation and regulatory decision-making. This paper proposes a structured, question-driven framework to guide exploratory assessments of regional heterogeneity in MRCTs. We formulate four key questions to clarify the objectives of such analyses and propose a set of statistical methods to address them. Simulation studies evaluate performance under scenarios with no heterogeneity and heterogeneity driven by observed or unobserved treatment effect modifiers, illustrating how a structured approach can support transparent and cautious interpretation. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2605_16885 |
| institution | arXiv |
| publishDate | 2026 |
| record_format | arxiv |
| spellingShingle | A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials Zhang, Cong Long, Meihua Zheng, Tianyu Sechidis, Konstantinos Liu, Xiaoni Sun, Sophie Chen, Yao Zhang, Xinyi Kaneko, Shuhei Bornkamp, Björn Hou, Yan Applications Methodology Multi-regional clinical trials (MRCTs) enable efficient global drug development by assessing treatment effects across regions within a single protocol. While powered for overall efficacy, MRCTs are typically not designed to provide confirmatory evidence on regional differences, making an assessment of observed regional heterogeneity largely exploratory and susceptible to sampling variability. Despite this challenge, understanding regional heterogeneity remains important for interpretation and regulatory decision-making. This paper proposes a structured, question-driven framework to guide exploratory assessments of regional heterogeneity in MRCTs. We formulate four key questions to clarify the objectives of such analyses and propose a set of statistical methods to address them. Simulation studies evaluate performance under scenarios with no heterogeneity and heterogeneity driven by observed or unobserved treatment effect modifiers, illustrating how a structured approach can support transparent and cautious interpretation. |
| title | A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials |
| topic | Applications Methodology |
| url | https://arxiv.org/abs/2605.16885 |